A Spatially Distributed Microneedle System for Bioorthogonal T Cell‐Guided Cancer Therapy
Advanced Science · 2025-04 · 12 (13)
DOI: 10.1002/advs.202416841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.02.2025. Verfasst von Lanya Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, 523059, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Needles, Immunotherapy, Adoptive, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)‐T cell therapy represents a promising strategy for cancer treatment. However, the diversity of solid tumor antigens and the poor infiltration of CAR‐T cells significantly hinder the efficacy of CAR‐T therapies against tumors. Here, a spatially distributed microneedle system (SDMNS) is developed that leverages bioorthogonal reactions to activate and guide endogenous T cells to tumors for effective destruction. The SDMNS consists of two dissolving microneedles, each loaded with complementary bioorthogonal groups and applied separately to lymph nodes and tumor sites. One microneedle loaded with two dibenzocyclooctyne (DBCO)‐modified antibodies activates T cells and labels them with bioorthogonal groups in lymph nodes. The other microneedle, containing N‐azidoacetylmannosamine‐tetraacylated (Ac4ManNAz) for glycometabolic labeling of tumor cells, and the T cell chemotactic factor IP10, is applied directly to the tumor site. The in vivo studies demonstrate that SDMNS effectively directs the migration and infiltration of endogenous activated T cells into the tumors. Through a bioorthogonal click reaction, DBCO‐modified T cells conjugate with azide (N 3 )‐modified tumor cells, eliciting robust antitumor immune responses and durable immune memory. The SDMNS offers a novel strategy to overcomes tumor heterogeneity by facilitating the directed migration of endogenous T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, 523059, China.
- Dongguan Key Laboratory of Basic, Clinical and Digital Research on Common Orthopedic Diseases, Dongguan, 523059, China.
- College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, 071002, China.
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
- Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzhou, 510515, China.
ORCID-Profile: Zhenhua Li
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Li, L., Wang, F., Mo, S., Deng, J., Wang, X., Ai, J., Xiao, Y., Zeng, Y., Li, Q., Zhang, Y., Cai, L., & Li, Z. (2025). A Spatially Distributed Microneedle System for Bioorthogonal T Cell‐Guided Cancer Therapy. Advanced Science, 12(13). https://doi.org/10.1002/advs.202416841
Vancouver
Li L, Wang F, Mo S, Deng J, Wang X, Ai J, et al. A Spatially Distributed Microneedle System for Bioorthogonal T Cell‐Guided Cancer Therapy. Advanced Science. 2025;12(13). doi:10.1002/advs.202416841
BibTeX
@article{Li2025,
author = {Li, Lanya and Wang, Fei and Mo, Shushan and Deng, Junyao and Wang, Xueyi and Ai, Jiacong and Xiao, Yingxian and Zeng, Yan and Li, Qishan and Zhang, Yixin and Cai, Limin and Li, Zhenhua},
title = {A Spatially Distributed Microneedle System for Bioorthogonal T Cell‐Guided Cancer Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {13},
doi = {10.1002/advs.202416841}
}
EUVIMED